Catecholamines & Neurologic Diseases
NEJM 293:274, Moskowitz,M.A.,et al, 1975
Cholinergic Vesicular Transporters in Progressive Supranuclesar Palsy
Neurol 58:1013-1018,997, Suzuki,M.,et al, 2002
Excitatory Amino Acids as a Final Common Pathway for Neurologic Disorders
NEJM 330:613-622, Lipton,S.A.&Rosenberg,P.A., 1994
A Controlled Trial of Riluzole in Amyotrophic Lateral Sclerosis
NEJM 330:585-591, Bensimon,G.,et al, 1994
Extracellular Hippocampal Glutamate and Spontaneous Seizure in the Conscious Human Brain
Lancet 341:1607-1610, 16271993., During,M.J.&Spencer,D.D., 1993
Chronic Daily Headache
Neurol 42:32-36, Sheftell,F.D., 1992
Multistate Outbreak of Poisonings Associated with Illicit Use of Gamma Hydroxy Butyrate
JAMA 265:447-448, , 1991
The Bioloigcal Basis for the Treatment of Acute Stroke
Neurol 41:1867-1873, Scheinberg,P., 1991
Alzheimer's Disease
NEJM 314:964-973, Katzman,R., 1986
Neural Transplantation:Scientific Gains & Clinical Perspectives
Neurol 36:389-392, Fishman,P.S., 1986
The Role of Glutamate in Neurotransmission & in Neurologic Disease
Arch Neurol 43:1058-1063, Greenamyre,J.T., 1986
Neurochemical Studies of Early Onset Alzheimer's Disease, Possible Influence on Treatment
NEJM 313:7-11, Francis,P.T.,et al, 1985
Neurotransmitters & CNS Disease, Basal Ganglia Disease
Lancet 2:1141-1147, Marsden,C.D., 1982
Neurotransmitters & CNS Disease
Lancet 2:914-918, Iversen,L.L., 1982
The Neuropharmacology of Depression
Dis Nerv Sys 38:841-846, Adolphe,A.B.,et al, 1977